2 GL Outsourcing will support Clinerion in expanding the coverage of the Patient Network Explorer platform to patients and hospitals in Serbia, and Bosnia and Herzegovina, who will be matched to sponsored, international clinical trials.
2 GL Outsourcing is a pharmaceutical and clinical contract research and outsourcing organization providing a full range of professional services for the setting up and support of clinical research and development projects. 2 GL’s scope of operations covers the territories of Serbia, Croatia, Slovenia, North Macedonia, Montenegro and Bosnia and Herzegovina. The company also has partnerships in Bulgaria, Hungary, Russia and Kazakhstan.
With this partnership, 2 GL will support the expansion of the network of partner hospitals on the Patient Network Explorer platform to the countries 2 GL covers, leveraging its clinical research ecosystem in the region. In addition, 2 GL will also support the start-up and conducting of trials at sites joining the Clinerion network.
Separately and in combination, Clinerion and 2 GL’s services will accelerate access for patients and hospitals to next-generation medical treatments. Patients in the region will become more visible to sponsors for trial recruitment, and hospitals in the region will become better placed to run clinical trials.
Patient Network Explorer matches patients from Clinerion’s global network of hospitals to clinical trials run by pharmaceutical sponsors. The system is based on de-identified EHR data, unlinked from any identifiers, protecting patient privacy.
“Clinerion is working hard to bring medicines quicker to patients around the world,” says Ian Rentsch, Clinerion CEO. “2 GL offers a great network which can support the expansion of our coverage in the region.”
For more information go to www.clinerion.com
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.